Search
The Newsletter
The Principals
Reports
Conferences
Databases
Custom Research
Contact Us
 
Home
 
Keynote Speakers (TBA)
Industry Panel Discussion (TBA)


The Largest East Coast Strategic Partnership and Investment Meeting for Medical Technology Executives

Register Before August 31st and Save $200!
First Registrant: $200 off!

 
Add'l registrant from same company/location: $300 off!

Register for Medical Device Investor Day
Registration (Investor Day Only): Register

 
Registration (Includes In3 East): Register

REGISTER TODAY!


In3 East is simply where you will meet the most important people in medical technology partnering.
As the largest East Coast strategic partnership and investment meeting for senior-level medical technology executives, hundreds of venture capital companies and medical technology companies gather each year to hear about the latest innovations and investment opportunities, especially in the following areas:

  • Cardiovascular/Interventional Cardiology
  • Diagnostics
  • Drug Delivery
  • Imaging
  • Minimally Invasive Surgery
  • Nanotechnology
  • Neurostimulation
  • Orthopedics/Spine
  • Peripheral Vascular
  • Stem Cells
  • Stroke Management
  • Wound Management

... among many other high-growth areas

And when you’re not networking, you’ll benefit from any of the following discussed at the meeting:

  • Keynote presentations, on-stage interviews, investment and financing panel discussions by prominent device industry executives
  • Venture capital dealmaking presentations
  • Buy side panels
  • Educational workshops for start-up companies
  • Company presentations from more than 50 emerging medical technology companies seeking funding and/or strategic partnership


Advisory Board

Jeffrey Barnes
General Partner
Oxford Bioscience Partners

Annette Campbell-White
Senior Managing Member MedVenture Associates

Michael Carusi
General Partner
Advanced Technology Ventures

Luke Evnin
General Partner
MPM Capital

Richard M. Ferrari
Managing Director
DeNovo Ventures

William T. Harrington
Partner
Three Arch Partners

Ross A. Jaffe
Managing Director
Versant Ventures

Ellen Koskinas
Partner
InterWest Partners

Josh Makower
Venture Partner
NEA

John Maroney
General Partner
Delphi Ventures

David Milne
Managing Partner
SV Life Science Advisers

Trevor J. Moody
Partner
Frazier Healthcare Ventures

Jesse I Treu
Partner
Domain Associates

For more information, please contact Kristy Grimes at 480-985-9512, 888-202-5939 toll-free in the U.S., or e-mail in3@windhover.com

back to top

Presenting Companies

Presenting Companies/
Locations

Technologies

Advanced BioSensors, Inc.
Mentor, OH

(technology description available soon at http://www.windhover.com/in3east08)
AugmentRx Medical, Inc. (First-Time Presenter)
Shelburne, VT
AugmentRx(TM): Injectable porous scaffolds, spheres and composites with fully interconnected pores. Nonmigratory, nonantigenic providing sustainable tissue volume and stability for multiple applications.
Axogen, Inc. (First-Time Presenter)
Gainesville, FL
We return quality of life to patients by creating and delivering superior peripheral nerve solutions.
BioLineRx, Ltd. (First-Time Presenter)
Jerusalem, Israel
BioLineRx is a clinical stage company developing a novel injectable biopolymer for the direct treatment of AMI.
BoneGrafix (First-Time Presenter)
Rockfield, MD
(technology description available soon at http://www.windhover.com/in3east08)
Cardiola, Ltd.
Winterthur, Switzerland
Non-invasive Chronic Heart Failure treatment device with CE certification using patented Muscular Counter Pulsation (MCP) technology.
CardioMag Imaging, Inc. (First-Time Presenter)
Schenectady, NY
CardioMag - Non invasive devices to identify patients with coronary artery disease and other life threatening cardiovascular conditions.
Ceragenix Pharmaceuticals
Denver, CO
Ceragenix Pharmaceuticals is developing its "Cerashield" line of antimicrobial coatings to prevent microbial colonization and biofilm formation of endotracheal tubes and other indwelling medical devices.
Cerapedics, Inc.
Westminster, CO

Cerapedics, Inc. is developing and commercializing innovative osteobiologic products based on its proprietary small peptide technology for spine, trauma and orthopaedic applications.

Cohera Medical, Inc.
Pittsburgh, PA

Cohera Medical is developing TissuGlu™, a biodegradable surgical adhesive for seroma reduction in plastic surgery.
Core Essence Orthopaedics LLC. (First-Time Presenter)
Yardley, PA

Core Essence Orthopaedics, Inc. is a privately held orthopaedic device company focused on intuitive, enabling solutions for minimally invasive soft tissue and arthroscopic musculoskeletal repair.

CoreSpine Technologies
Minneapolis, MN
CoreSpine - CoreSpine will prepare the spinal disc for a nucleus replacement or minimally invasive fusion device.
Curative Biosciences, Inc. (First-Time Presenter)
Waltham, MA

Curative Biosciences Inc. - Leader in the development of novel, proprietary biomaterial and biologic combination products for the repair and regeneration of orthopaedic injury.
Delcath Systems, Inc. (First-Time Presenter)
New York, NY

Delcath is a developmental stage medical device company testing a high-dose drug delivery system for the treatment of liver cancers.
DermTech International
LaJolla, CA

DermTech is developing non-invasive molecular diagnostics for the early detection of melanoma and other diseases, theranostics and drug development.
eCardio Diagnostics
The Woodlands, TX

eCardio Diagnostics, www.eCardio.com, is the leading North American provider of comprehensive and advanced technologies, devices, services and solutions for the diagnosis, monitoring, and subsequent clinical management of cardiac arrhythmias.
Endosense SA
Geneva, Switzerland
Endosense SA -Company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias.
EndoSphere Inc. (First-Time Presenter)
Redwood City, CA
EndoSphere is in human trials with an endoscopically implantable device that assists patients in losing weight and controlling Type 2 diabetes.

Envisionier Medical Technologies
Rockville, MD
Envisionier Medical Technologies, Inc. is the leader in development of portable endoscopic imaging technology with the endogo® visualization system and related products.
EyeMarker Systems, Inc. (First-Time Presenter)
Morgantown, WV
EyeMarker Systems - Automated handheld RTD1000 (3lbs) provides rapid (3 minutes), non-invasive triage and detection of pre-symptomatic exposure to systemic diseases, toxins, and internal injury via the eye.

FAST (First-Time Presenter)
Indianapolis, IN

FAST Diagnostics is using fluorescent markers and optical sensors to develop a measurement of kidney function.
Genesis Medical Interventional, Inc.
Redwood City, CA

Gensis Medical - Instant On/Instant Off Proximal Occlusion Funnel Catheter™ for Embolectomy and Thrombectomy during Percutaneous Vascular Procedures.
Healionics Corporation
Redmond, WA

3D tissue scaffold materials and structures providing enhanced biocompatibility and bio-integration of medical devices.

HydroCision, Inc.
Billerica, MA

Fluidjet devices for open/MIS spine procedures including fusion, discectomy, artificial nucleus, and disc procedures.

Intellwave, LLC
Edison, NJ

Intellewave LLC - World wide leader in Heart Rate Variability (HRV) analysis for quantitative assessment of the Autonomic Nervous System (ANS) - 510k clearance - Columbia Univeristy validated.

LifeBond Ltd. (First-Time Presenter)
Caesarea, Israel
LifeBond is developing strongly adhesive sealants and hemostats for surgical use. The natural polymer technology mimics the physiological clotting cascade without reliance on blood-derived proteins and can be used to staunch severe bleeding, reinforce staple and suture lines, and repair tissues.
LineaGen, Inc. (First-Time Presenter)
Salt Lake City, UT

Content-based biomarker discovery company focused on the commercialization of novel, patentable diagnostic tests.
MicroTransponder Inc. (First-Time Presenter)
Dallas, TX
MicroTransponder has developed a wireless neurostimulation device to treat refractory chronic pain. Our device is 100 times smaller than current technology and injectable via a minimally invasive hypodermic needle.

Minnow Medical
San Diego, CA
New catheter treatment to restore blood flow to arteries by reducing plaque volume and increasing the artery diameter.
mNemoscience GmbH
Aachen, Germany

mNemoscience is pioneering the design and manufacture of innovative biocompatible shape memory polymers (BIO-SMP) which can be programmed to change shapes and rigidity when an initiating stimulus, such as e.g. change in temperature, is applied.
MST (Medical Smart Tools) (First-Time Presenter)
Nazareth, Israel

MST (Medical Smart Tools) development of advanced visualization-guided technology solutions that improve laparoscopic surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes.
MTM Laboratories (First-Time Presenter)
Westborough, MA
Biomarkers for the screening and diagnosis of cancers; initial focus is on Cervical Cancer.
nContact Surgical, Inc. (First-Time Presenter)
Morrisville, NC

nContact Surgical is focused on commercializing novel cardiac coagulation systems that enable endoscopic, “port access” minimally invasive for the treatment of atrial fibrillation.
NeoMend, Inc.
Irvine, CA

NeoMend Inc. - NeoMend is a biomaterials company commercializing advanced wound management products based upon its proprietary polymer hydrogel technology.
Nerites Corporation
Madison, WI
Nerites Corporation develops fully-synthetic, water-resistant adhesives, sealants, and coatings for internal medical use. The hydrogel technology can be used to close internal tears or incisions, to seal tissues and prevent leakage and infection, and to affix synthetic or biologic medical devices.

Osprey Medical (First-Time Presenter)
St. Paul, MN
Osprey Medical’s CINCOR™ system is designed to prevent contrast media, used in coronary procedures, from causing kidney damage.
PEAK Surgical, Inc. (First-Time Presenter)
Palo Alto, CA
PEAK Surgical’s technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral tissue damage
Polymedix, Inc.
Radnor, PA
Novel anti-microbial polymeric coatings for devices and implants.
Sage Technology & Development (First-Time Presenter)
Idaho Falls, ID
Approximator™ soft tissue approximation and fastening technology enables the simplest, safest, easiest-to-perform and lowest cost gastric volume reduction procedure for effective weight loss.
Sensimed AG (First-Time Presenter)
Lausanne, Switzerland

(technology description available soon at http://www.windhover.com/in3east08)
Sentinel Group LLC. (First-Time Presenter)
Grand Rapids, MI

A removable minimally invasive device to treat obesity by inducing satiety in the esophageal / cardiac portion of the stomach placed via endoscopy (www.SentinelGroupLLC.com).
Sherlock-NMD (First-Time Presenter)
Hidden Valley Lake, CA

Sherlock-NMD is a non-invasive biomechanical diagnostic system that records and analyzes human range of motion (ROM) in a full 3D environment. It provides real-time diagnostic images of neuro-muscular-skeletal function and dysfunction of the human body in motion.
SonoMedix (First-Time Presenter)
Doylestown, PA

SonoMedix (-EZ- INR, is an easy to use blood coagulation monitoring system for use by patients and healthcare professionals in the management of warfarin therapy.
Spinal Elements
Carlsbad, CA

Zyre™ Facet Arthroplasty System Minimally invasive, tissue sparing, reversible.

Symbios Medical
Indianapolis, IN

Symbios The Symbios GOPump™ Rapid Recovery System provides postoperative pain relief for patients more effectively than narcotics.
TissueGen, Inc. (First-Time Presenter)
Dallas, TX

(technology description available soon at http://www.windhover.com/in3east08)
Urovalve, Inc.
Newark, NJ

(technology description available soon at http://www.windhover.com/in3east08)

Victhom Human Bionics Inc.
Quebec, Canada

Victhom's Neurobionix business unit focuses on the development and commercialization of technologies and products involving implantable devices that features neurosensing and neurostimulation components, integrated with artificial intelligence

ViOptix, Inc. (First-Time Presenter)
Fremont, CA
ViOptix Inc - Optical Diffusion Imaging and Spectroscopy (ODIS) technology which enables non-invasive, direct, real-time measurement of local tissue oxygen saturation.
Vivostat A/S
Alleroed, Denmark
Vivostat A/S manufactures and sells a surgical sealant and a gel to treat chronic wounds. Both are based on the individual patients own blood. A third product can be used as a drug delivery media for topical use.

Xylos Corporation
Langhorne, PA

Xylos Corporation is a medical device company that develops unique biomaterials based on proprietary biocellulose technology for the treatment, repair and replacement of human tissue.

 

Top reasons to attend In3 East:

  • Catch up on the state of medical technology investment and partnering
  • Network with peers who face similar challenges in regulatory, reimbursement and clinical issues for medical devices
  • Benchmark your dealmaking against the best and the brightest
  • Winners and losers: Find out which companies and technologies are worth the investment
  • Get key trend analysis on medical technology deal structures
  • Maximize your strategic alliance opportunities by meeting business development leaders who’ll share practical advice and strategies on how to structure successful deals
  • Walk away with practical, real-life lessons from some of the most experienced dealmakers in the industry in the medical technology marketplace
  • Attended by senior-level decision-makers from the investment community and major medical technology, biopharmaceutical, biotech, venture capital and other companies
  • More than 50 participating companies
  • 10-minute presentations immediately followed by private, one-on-one meetings with company representatives
  • A range of technologies for such high-growth segments of the medtech industry as interventional cardiology, spinal and orthopedic surgery, drug delivery technology, and stroke management

Maximize your strategic alliance opportunities by hearing C-level, venture capital and business development executives who share lessons learned, practical advice and strategies on medical technology dealmaking.

In3 East has the most senior execs in attendance:

  • Presidents
  • CEOs
  • Chairmen
  • Venture Partners
  • Managing Directors
  • Vice Presidents/Directors of Business Development, Marketing, New Technology, Acquisitions, R & D & Sales
  • Senior Investment Analysts/Managers/Directors

If you're on this list, you must attend this meeting.

  • Established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength
  • Venture capitalists and investment bankers
  • Medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships

back to top

Program Agenda

Wednesday, October 22, 2008
8:00-5:30 p.m. Medical Device Investor Day (Separate Registration Required)

Wednesday, October 22, 2008

5:30-7:30 p.m. Registration & Welcome Reception
6:00-7:30 p.m. Pre-Conference Panel Discussion

Panelist:
Chris Velis - Medical Capital Advisors

Thursday, October 23, 2008

7:30-8:30 a.m. Registration & Continental Breakfast
8:30 a.m. Welcome/Opening
8:30-9:30 a.m.

Keynote Panel Discussion

Stories behind How Financing Deals got Done
• Why we invested in certain technologies/clinical spaces

• What kind of due diligence got done

• How valuations were determined

• What was the rationale behind the deal from an in investment point of view

Panelists:
David Milne, Managing Partner, SV Life Science Advisers LP
Kevin Connors, General Partner, Spray Venture Partners
Amir Nashat, General Partner, Polaris Ventures

9:35-5:30 p.m. Company Presentations

Workshops

 

12:30-1:30 p.m. Lunch
5:30-6:00 p.m. Sponsor Supported Networking Session 
6:00-7:30 p.m Presenting Company Product Exhibits/Networking Reception

Friday, October 24, 2008

7:45-8:30 a.m. Registration & Continental Breakfast

8:30-9:30 a.m.

Panel Discussion

FDA Update: Tips for Smooth and Successful Interactions with CDRH

• Get the latest news from Washington on IDEs, PMA review, the 510(k) process, device reclassifications and user fees

• Learn how to use the new Interactive Review process for pre-market submissions

• Understand CDRH’s changing expectations for 510(k) clearance


Panelists:
TBA

9:35-12:50 p.m. Company Presentations
10:30-10:45 a.m. Morning Break
1:00 p.m. Box Lunch & Conference Concludes

Note: Program subject to change; check back for regular updates.

 

*Cancellation Policy: The last day to cancel your registration for a refund, minus a $300 processing fee, is September 20, 2008. After that, you may send another delegate from your company.

 


Sponsored by:

 

 

 

Financial Contributor

Major Supporting Publication